Characteristics | No of patients (n = 14) | Percent |
---|---|---|
Gender | Â | Â |
 Male | 6 | 42.9 |
 Female | 8 | 57.1 |
Age, median (range)/years | 56.5 (14-81) | |
Performance status (ECOG) | Â | |
 0–1 | 13 | 92.9 |
 2 | 1 | 7.1 |
Stage at diagnosis (Masaoka-Koga) | Â | Â |
 IVa | 3 | 21.4 |
 IVb | 8 | 57.1 |
 Recurrence | 3 | 21.4 |
Metastatic sites (overlapped) | Â | Â |
 Lung | 6 |  |
 Liver | 2 |  |
 Lymph nodes | 5 |  |
 Pleura | 5 |  |
 Bone | 3 |  |
 Brain | 1 |  |
Histologic subtype | Â | Â |
 Squamous cell carcinoma | 12 | 85.7 |
 Lymphoepithelioma-like carcinoma | 1 | 7.1 |
 Undifferentiated carcinoma | 1 | 7.1 |
Previous chemotherapy | Â | Â |
 ADOC | 3 |  |
 Cisplatin-irinotecan | 9 |  |
 Cisplatin-gemcitabine | 1 |  |
 Carboplatin-gemcitabine | 1 |  |